Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1988 1
1989 5
1990 2
1991 1
1993 1
1994 2
1998 2
1999 1
2000 5
2001 5
2002 4
2003 7
2004 6
2005 3
2006 3
2008 4
2009 9
2010 11
2011 10
2012 9
2013 8
2014 10
2015 4
2016 7
2017 22
2018 17
2019 8
2020 15
2021 11
2022 5
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Chi KN, Rathkopf D, Smith MR, Efstathiou E, Attard G, Olmos D, Lee JY, Small EJ, Pereira de Santana Gomes AJ, Roubaud G, Saad M, Zurawski B, Sakalo V, Mason GE, Francis P, Wang G, Wu D, Diorio B, Lopez-Gitlitz A, Sandhu S; MAGNITUDE Principal Investigators. Chi KN, et al. J Clin Oncol. 2023 Jun 20;41(18):3339-3351. doi: 10.1200/JCO.22.01649. Epub 2023 Mar 23. J Clin Oncol. 2023. PMID: 36952634 Free PMC article. Clinical Trial.
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma.
Loriot Y, Matsubara N, Park SH, Huddart RA, Burgess EF, Houede N, Banek S, Guadalupi V, Ku JH, Valderrama BP, Tran B, Triantos S, Kean Y, Akapame S, Deprince K, Mukhopadhyay S, Stone NL, Siefker-Radtke AO; THOR Cohort 1 Investigators. Loriot Y, et al. N Engl J Med. 2023 Nov 23;389(21):1961-1971. doi: 10.1056/NEJMoa2308849. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870920 Clinical Trial.
Erdafitinib versus pembrolizumab in pretreated patients with advanced or metastatic urothelial cancer with select FGFR alterations: cohort 2 of the randomized phase III THOR trial.
Siefker-Radtke AO, Matsubara N, Park SH, Huddart RA, Burgess EF, Özgüroğlu M, Valderrama BP, Laguerre B, Basso U, Triantos S, Akapame S, Kean Y, Deprince K, Mukhopadhyay S, Loriot Y; THOR cohort 2 investigators. Siefker-Radtke AO, et al. Ann Oncol. 2024 Jan;35(1):107-117. doi: 10.1016/j.annonc.2023.10.003. Epub 2023 Oct 21. Ann Oncol. 2024. PMID: 37871702 Clinical Trial.
Cancer and aging in Ibero-America.
Soto-Perez-de-Celis E, Cordoba R, Gironés R, Karnakis T, Paredero I, Chavarri-Guerra Y, Navarrete-Reyes AP, Avila-Funes JA. Soto-Perez-de-Celis E, et al. Among authors: girones r. Clin Transl Oncol. 2018 Sep;20(9):1117-1126. doi: 10.1007/s12094-018-1844-1. Epub 2018 Feb 12. Clin Transl Oncol. 2018. PMID: 29435944 Review.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Looking for a needle in a haystack. SARS-CoV-2 variant characterization in sewage.
Itarte M, Bofill-Mas S, Martínez-Puchol S, Torrell H, Ceretó A, Carrasco M, Forés E, Canela N, Girones R, Rusiñol M. Itarte M, et al. Among authors: girones r. Curr Opin Environ Sci Health. 2021 Dec;24:100308. doi: 10.1016/j.coesh.2021.100308. Epub 2021 Nov 6. Curr Opin Environ Sci Health. 2021. PMID: 34849439 Free PMC article. Review.
Can we avoid the toxicity of chemotherapy in elderly cancer patients?
Feliu J, Heredia-Soto V, Gironés R, Jiménez-Munarriz B, Saldaña J, Guillén-Ponce C, Molina-Garrido MJ. Feliu J, et al. Among authors: girones r. Crit Rev Oncol Hematol. 2018 Nov;131:16-23. doi: 10.1016/j.critrevonc.2018.08.008. Epub 2018 Aug 28. Crit Rev Oncol Hematol. 2018. PMID: 30293701 Review.
Virus hazards from food, water and other contaminated environments.
Rodríguez-Lázaro D, Cook N, Ruggeri FM, Sellwood J, Nasser A, Nascimento MS, D'Agostino M, Santos R, Saiz JC, Rzeżutka A, Bosch A, Gironés R, Carducci A, Muscillo M, Kovač K, Diez-Valcarce M, Vantarakis A, von Bonsdorff CH, de Roda Husman AM, Hernández M, van der Poel WH. Rodríguez-Lázaro D, et al. Among authors: girones r. FEMS Microbiol Rev. 2012 Jul;36(4):786-814. doi: 10.1111/j.1574-6976.2011.00306.x. Epub 2011 Oct 24. FEMS Microbiol Rev. 2012. PMID: 22091646 Free PMC article. Review.
190 results